Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Arrhythmias

  Free Subscription


Articles published in BMJ

Retrieve available abstracts of 48 articles:
HTML format
Text format



Single Articles


    February 2018
  1. KUMAR S, de Lusignan S, McGovern A, Correa A, et al
    Ischaemic stroke, haemorrhage, and mortality in older patients with chronic kidney disease newly started on anticoagulation for atrial fibrillation: a population based study from UK primary care.
    BMJ. 2018;360:k342.
    PubMed     Text format     Abstract available


    December 2017

  2. Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis.
    BMJ. 2017;359:j5631.
    PubMed     Text format    


    November 2017
  3. LOPEZ-LOPEZ JA, Sterne JAC, Thom HHZ, Higgins JPT, et al
    Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis.
    BMJ. 2017;359:j5058.
    PubMed     Text format     Abstract available


  4. BALL J
    Which anticoagulant for stroke prevention in atrial fibrillation?
    BMJ. 2017;359:j5399.
    PubMed     Text format    


  5. CHATTERJEE D
    A young man with palpitations and pre-syncope.
    BMJ. 2017;359:j4846.
    PubMed     Text format    


    October 2017
  6. MAYOR S
    Men develop atrial fibrillation 10 years earlier than women, finds study.
    BMJ. 2017;359:j4802.
    PubMed     Text format    


  7. FLOYD CN, Ferro A
    Indications for anticoagulant and antiplatelet combined therapy.
    BMJ. 2017;359:j3782.
    PubMed     Text format    


    September 2017
  8. TORJESEN I
    Over 15% of atrial fibrillation patients are not prescribed any antithrombotic agent for stroke prevention by GPs.
    BMJ. 2017;358:j4467.
    PubMed     Text format    


    July 2017
  9. ABI KHALIL C, Haddad F, Al Suwaidi J
    Investigating palpitations: the role of Holter monitoring and loop recorders.
    BMJ. 2017;358:j3123.
    PubMed     Text format    


    June 2017
  10. DAVIES RH, Thomas DE
    Heart rhythm conundrum.
    BMJ. 2017;357:j2215.
    PubMed     Text format    


    May 2017
  11. CHATTERJEE D
    A case of palpitation and pre-syncope.
    BMJ. 2017;357:j2343.
    PubMed     Text format    


  12. HIPPISLEY-COX J, Coupland C, Brindle P
    Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study.
    BMJ. 2017;357:j2099.
    PubMed     Text format     Abstract available


  13. MILLER EO, Krishnamoorthy VK, Ling FSK, Chaturvedi A, et al
    A man with chest pain and acute ST elevations on electrocardiogram.
    BMJ. 2017;357:j2198.
    PubMed     Text format    


  14. YI Z, Huang YS, Wang L, Zhao YT, et al
    A man with chest tightness and burning limbs.
    BMJ. 2017;357:j1979.
    PubMed     Text format    


    February 2017

  15. Atrial fibrillation stroke worse in women . . . and other stories.
    BMJ. 2017;356:j819.
    PubMed     Text format    


  16. NIELSEN PB, Skjoth F, Sogaard M, Kjaeldgaard JN, et al
    Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study.
    BMJ. 2017;356:j510.
    PubMed     Text format     Abstract available


  17. WISE J
    Multiple pregnancies may increase a woman's risk of atrial fibrillation.
    BMJ. 2017;356:j609.
    PubMed     Text format    


    November 2016
  18. MAYOR S
    More than half of stroke patients were not given preventive drugs, study finds.
    BMJ. 2016;355:i6105.
    PubMed     Text format    


  19. SUKKAR L, Hong D, Wong MG, Badve SV, et al
    Effects of ischaemic conditioning on major clinical outcomes in people undergoing invasive procedures: systematic review and meta-analysis.
    BMJ. 2016;355:i5599.
    PubMed     Text format     Abstract available


    October 2016
  20. MOORE TJ
    Optimal dosing of rivaroxaban is undefined.
    BMJ. 2016;355:i5549.
    PubMed     Text format    


  21. TORJESEN I
    Bleeding risk higher with rivaroxaban than dabigatran for stroke prevention, head-to-head trial shows.
    BMJ. 2016;355:i5362.
    PubMed     Text format    


    August 2016
  22. WISE J
    Most patients taking warfarin do not maintain stable INR values.
    BMJ. 2016;354:i4402.
    PubMed     Text format    


    June 2016

  23. QT interval and drug therapy.
    BMJ. 2016;353:i2732.
    PubMed     Text format    


  24. DUKES JW, Dewland TA, Vittinghoff E, Olgin JE, et al
    Access to alcohol and heart disease among patients in hospital: observational cohort study using differences in alcohol sales laws.
    BMJ. 2016;353:i2714.
    PubMed     Text format     Abstract available


    January 2016
  25. EMDIN CA, Wong CX, Hsiao AJ, Altman DG, et al
    Atrial fibrillation as risk factor for cardiovascular disease and death in women compared with men: systematic review and meta-analysis of cohort studies.
    BMJ. 2016;532:h7013.
    PubMed     Text format     Abstract available


  26. MCCARTHY M
    No link between macrolide antibiotics and ventricular arrhythmias, study finds.
    BMJ. 2016;352:i1083.
    PubMed     Text format    


  27. FERRO A
    Newer antiplatelet agents in acute coronary syndrome.
    BMJ. 2016;352:h7025.
    PubMed     Text format    


  28. GALE CP, Camm AJ
    Assessment of palpitations.
    BMJ. 2016;352:h5649.
    PubMed     Text format    


  29. BEALES IL
    Decisions on restarting anticoagulation should be made earlier after rebleeding.
    BMJ. 2016;532:i248.
    PubMed     Text format    


  30. STAERK L, Lip GY
    Authors' reply to Beales.
    BMJ. 2016;532:i266.
    PubMed     Text format    


  31. WANG SV, Franklin JM, Glynn RJ, Schneeweiss S, et al
    Prediction of rates of thromboembolic and major bleeding outcomes with dabigatran or warfarin among patients with atrial fibrillation: new initiator cohort study.
    BMJ. 2016;353:i2607.
    PubMed     Text format     Abstract available


  32. COHEN D
    Rivaroxaban: can we trust the evidence?
    BMJ. 2016;352:i575.
    PubMed     Text format    


  33. WISE J
    Atrial fibrillation in women is linked to increased risk of cancer.
    BMJ. 2016;353:i2982.
    PubMed     Text format    


  34. WISE J
    Telling patients of incidental genetic findings is questionable, researchers warn.
    BMJ. 2016;352:h7034.
    PubMed     Text format    


  35. JASPERS FOCKS J, Brouwer MA, Wojdyla DM, Thomas L, et al
    Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trial.
    BMJ. 2016;353:i2868.
    PubMed     Text format     Abstract available


  36. LARSEN TB, Skjoth F, Nielsen PB, Kjaeldgaard JN, et al
    Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study.
    BMJ. 2016;353:i3189.
    PubMed     Text format     Abstract available


  37. INGHAMMAR M, Svanstrom H, Melbye M, Pasternak B, et al
    Oral fluoroquinolone use and serious arrhythmia: bi-national cohort study.
    BMJ. 2016;352:i843.
    PubMed     Text format     Abstract available


  38. MOORE M, Hopkins J, Wainwright P
    Primary care management of patients after weight loss surgery.
    BMJ. 2016;352:i945.
    PubMed     Text format    


  39. BRADLEY SM, Liu W, Chan PS, Nallamothu BK, et al
    Defibrillation time intervals and outcomes of cardiac arrest in hospital: retrospective cohort study from Get With The Guidelines-Resuscitation registry.
    BMJ. 2016;353:i1653.
    PubMed     Text format     Abstract available


  40. COUPER K, Perkins GD
    Improving outcomes from in-hospital cardiac arrest.
    BMJ. 2016;353:i1858.
    PubMed     Text format    


  41. ODUTAYO A, Wong CX, Hsiao AJ, Hopewell S, et al
    Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis.
    BMJ. 2016;354:i4482.
    PubMed     Text format     Abstract available


  42. GULLAND A
    Small amounts of alcohol increase risk of atrial fibrillation, study finds.
    BMJ. 2016;354:i5041.
    PubMed     Text format    


  43. MAHTANI KR, Heneghan C
    Novel oral anticoagulants for atrial fibrillation.
    BMJ. 2016;354:i5187.
    PubMed     Text format    


  44. MONTASTRUC F, Montastruc G, Montastruc JL, Revet A, et al
    Cardiovascular safety of methylphenidate should also be considered in adults.
    BMJ. 2016;353:i3418.
    PubMed     Text format    


    January 2015
  45. LASSERSON D
    Restarting antithrombotic drugs after gastrointestinal haemorrhage in people with atrial fibrillation.
    BMJ. 2015;351:h6104.
    PubMed     Text format    


  46. STAERK L, Lip GY, Olesen JB, Fosbol EL, et al
    Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study.
    BMJ. 2015;351:h5876.
    PubMed     Text format     Abstract available


  47. ANDERSEN K, Rasmussen F, Held C, Neovius M, et al
    Exercise capacity and muscle strength and risk of vascular disease and arrhythmia in 1.1 million young Swedish men: cohort study.
    BMJ. 2015;351:h4543.
    PubMed     Text format     Abstract available


  48. COHEN D
    Data on trial of anticoagulant is to be reanalyzed after discovery that investigators used faulty device.
    BMJ. 2015;351:h6431.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: